18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients. - Wikidata - awgldk - TriplyDB

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.

http://www.wikidata.org/entity/Q37696901

about

Update on positron emission tomography for imaging of prostate cancer Updates of prostate cancer staging: Prostate-specific membrane antigen Imaging on nodal staging of prostate cancer.Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US.Preclinical lymphatic imaging.Molecular Imaging of Prostate Cancer Update on advances in molecular PET in urological oncology PET/CT in Oncology: Current Status and Perspectives.Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey.Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline Dual-phase PET-CT to differentiate [18F]Fluoromethylcholine uptake in reactive and malignant lymph nodes in patients with prostate cancer Management of urological malignancies: Has positron emission tomography/computed tomography made a difference?Combined PET imaging and diffusion-weighted imaging of intermediate and high-risk primary prostate carcinomas with simultaneous [18F] choline PET/MRI Assessment of Lymph Nodes and Prostate Status Using Early Dynamic Curves with (18)F-Choline PET/CT in Prostate Cancer PET/CT Imaging and Radioimmunotherapy of Prostate Cancer Molecular imaging of prostate cancer: PET radiotracers.A Clinical and Experimental Comparison of Time of Flight PET/MRI and PET/CT Systems Management of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm.11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction.Imaging in prostate cancer.18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review.Imaging in prostate cancer staging: present role and future perspectives.[18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.Choline PET/CT for imaging prostate cancer: an update.Individualized image-based lymph node irradiation for prostate cancer.Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.Initial prostate cancer diagnosis and disease staging--the role of choline-PET-CT.Imaging and evaluation of patients with high-risk prostate cancer.Surface-enhanced Raman spectroscopy of serum accurately detects prostate cancer in patients with prostate-specific antigen levels of 4-10 ng/mL Current use of PSMA-PET in prostate cancer management.(68)Ga-PSMA-11 PET/CT: the rising star of nuclear medicine in prostate cancer imaging?Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT.Serial 18F-choline-PET imaging in patients receiving enzalutamide for metastatic castration-resistant prostate cancer: response assessment and imaging biomarkers.18F Fluorocholine Dynamic Time-of-Flight PET/MR Imaging in Patients with Newly Diagnosed Intermediate- to High-Risk Prostate Cancer: Initial Clinical-Pathologic Comparisons.PET Tracers Beyond FDG in Prostate Cancer.PSMA PET and Radionuclide Therapy in Prostate Cancer.PET and PET/CT with radiolabeled choline in prostate cancer: a critical reappraisal of 20 years of clinical studies.Therapy assessment of bone metastatic disease in the era of 223radium.

P2860

Q27026828-EE8CD6DE-74E0-4DAD-8414-A9A1B10E2280 Q28079444-671356CE-4F58-46A9-B145-6659278EFB48 Q30244033-0E167CCF-BC49-454E-94E5-86F6A3854F98 Q30395717-156BA5A6-1D4F-4FD3-BE16-76FD074BF9F3 Q30465292-7A72FBF2-1B78-4C5D-9B68-BAF1C0CCC2F2 Q33620520-8CB0E036-1E10-492F-93FE-FE5F45BBF6F9 Q33625389-20F7C82F-8134-4221-A985-C5E9F89820CD Q33665109-19CDE167-DE0F-4DA4-832D-9E5C84E90773 Q34040036-8728EC19-6D43-488E-8C85-504EF5B523D2 Q34448553-C3BF9E0E-E381-40C1-8BDF-022007744AF8 Q34465066-A60D28D8-299C-4405-ADBF-9E7830AFE3B0 Q34990800-7E2CC8B1-98DC-4398-BD57-04E78A3551AE Q35208318-E95969EA-B024-4B07-BC1B-3848D0608A09 Q36039090-60DE9A30-7750-4B58-934B-44BD8C170445 Q36085426-A580348A-3FCC-44BB-BCAA-E92C2649FD88 Q36129937-85F32F80-78F4-423C-9712-9F8370F45B72 Q36621641-B29DF180-E6C3-4C96-BE6F-6CFA666FC727 Q37086178-D0A55278-6CF9-4BBB-859E-3616D42A9CF4 Q37209479-4B97D37A-AC71-4525-99A5-FC629981778A Q37875083-120632B3-96A3-4313-A12D-ED81F3071F22 Q37918311-71419FF9-F13D-49D5-8CD0-C70396D85D10 Q37973351-8C4D0E26-15D0-4B87-9AEA-88B6C7838603 Q37979650-9E3950F2-8552-4C29-8799-95F8244B0B5C Q38004182-F2D9AFB1-9368-4491-AA48-45C461156F47 Q38098441-9F613A9B-9070-4D13-ACD4-57B106149E61 Q38103180-2C0719C1-46F7-44CD-9EC2-899BC108256F Q38109812-6D8C49C0-2C59-48D9-B425-4FB54574841D Q38479113-98054475-9AAD-4C37-9FBE-A7409871B1E1 Q38564109-5DDA180B-4644-4526-9155-36EC47A29B38 Q38611187-80F3BA57-546B-4AF1-8B63-798A39444EFF Q38631489-002B3F4E-742F-4E80-A405-763496649C93 Q38744524-20C25FD8-0D79-4406-9662-B71DEB8ED6F3 Q38747415-0E53C8BA-45DD-4931-9D21-8708A38BB748 Q38814811-2714A57D-A177-4D7E-B135-1A5E437F9FBC Q38920663-4AEF07CA-A342-4C6D-9166-727E83F98972 Q38924757-9DC84372-5370-4AE5-9CC2-EB7A74D6589D Q39003086-BBFD3464-58F6-4DCF-AB33-ED29531C9B6D Q39003089-7F30F898-5C9B-4748-95EA-6F8E97CF9F6E Q39242140-8C0F479B-6021-4A38-AC5A-0384D9699627 Q39342954-953AC27D-0423-420C-91FB-7E4C21EFBAAA

P2860

18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.

http://www.wikidata.org/entity/Q37696901

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

18F choline PET/CT in the preo ...... pective study of 130 patients.

@en

18F choline PET/CT in the preo ...... pective study of 130 patients.

@nl

type

label

18F choline PET/CT in the preo ...... pective study of 130 patients.

@en

18F choline PET/CT in the preo ...... pective study of 130 patients.

@nl

prefLabel

18F choline PET/CT in the preo ...... pective study of 130 patients.

@en

18F choline PET/CT in the preo ...... pective study of 130 patients.

@nl

P1433

Q37696901-6F205A3D-800C-4FFB-B3EF-58D18A709442

P1476

Q37696901-10B9D164-FD65-4B5A-82E8-1ED5F4F16D8D

P2093

Q37696901-0432F8AA-C0C9-4D61-A872-919E5BB719D7

Q37696901-1F3B7B8E-9E9D-49EB-B1AA-000A8C197D12

Q37696901-5F02E555-1806-42A6-AE61-3B351974212E

Q37696901-76468E1F-EEC5-4E21-90A4-4C7FC6B561D3

Q37696901-9C3B0B3A-056C-43DE-ADC5-77EE14F458A0

Q37696901-A747E933-CE7A-4432-8A85-01BA5010F02A

Q37696901-BF0C83FE-2DF3-459C-BA71-5B2C58006DBA

Q37696901-C34A7D1F-03C2-443D-9F25-D380B145CD07

Q37696901-CCA04224-64B4-44FD-B561-5585619286A7

Q37696901-D4A82898-D3BB-4D1F-BEA3-CECF0CD24E01

P304

Q37696901-2C1D5D04-99A2-494B-9D8F-E0CEC0CCC4B0

P31

Q37696901-1BBB46CF-E3C8-4121-B630-0F779C025BD7

P356

Q37696901-D96AABE5-9F09-498C-BD02-2361DC678126

P407

Q37696901-B4D43CC9-96BC-4F31-8842-42721A50C6AB

P433

Q37696901-56985B41-C3FB-4470-9505-58F2A8C8373E

P478

Q37696901-905846BA-6F45-4E7E-B6B8-DA7EC7E31FAD

P577

Q37696901-E0FABB16-CB71-4467-9484-D9CBDA086791

P5875

Q37696901-7C939826-87FA-4C87-99D5-F6EF7E88C9BD

P698

Q37696901-A41E38AB-0DAC-4D90-9DE2-75E300AE2B4D

P921

Q37696901-B64C90F8-3ED7-491F-A423-5CE24F4DE941

P356

RADIOL.09090413

P1433

P1476

18F choline PET/CT in the preo ...... pective study of 130 patients.

@en

P2093

Bernhard Gruy

http://www.w3.org/2001/XMLSchema#string

Franz Stoiber

http://www.w3.org/2001/XMLSchema#string

Gabriele Broinger

http://www.w3.org/2001/XMLSchema#string

Guenter Janetschek

http://www.w3.org/2001/XMLSchema#string

Larisa Imamovic

http://www.w3.org/2001/XMLSchema#string

Michael Nader

http://www.w3.org/2001/XMLSchema#string

Mohsen Beheshti

http://www.w3.org/2001/XMLSchema#string

Peter Waldenberger

http://www.w3.org/2001/XMLSchema#string

Reza Vali

http://www.w3.org/2001/XMLSchema#string

Werner Langsteger

http://www.w3.org/2001/XMLSchema#string

P304

925-933

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.09090413

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

254

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41532513

http://www.w3.org/2001/XMLSchema#string

P698

20177103

http://www.w3.org/2001/XMLSchema#string

P921